1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 1-butanol in 4 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (1-butanol) | Trials (1-butanol) | Recent Studies (post-2010) (1-butanol) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 4,434 | 44 | 1,892 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bodlaj, R; Glaubitt, SI; Hübner, C; Krombach, F; Lehr, HA; Messmer, K; Münzing, S; Seiffge, D; von Andrian, UH | 1 |
| Adachi, T; Ito, Y; Liu, B; Nakashima, S; Nozawa, Y; Shimizu, T; Takano, T | 1 |
| Ashton, D; Fransen, JF; Hens, KA; Heylen, L; Hillen, LC; Janssens, F; Jurzak, MR; Leysen, JE; Mahieu, M; Megens, AA; Vermeire, JC; Vermote, PC | 1 |
| Chen, J; Tan, Z; Xu, Y; Zhu, M; Zhu, X | 1 |
4 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 1-butanol
| Article | Year |
|---|---|
In vitro effects of oxidized low density lipoprotein on CD11b/CD18 and L-selectin presentation on neutrophils and monocytes with relevance for the in vivo situation.
Topics: 1-Butanol; Adult; Animals; Butanols; CD18 Antigens; Cell Adhesion Molecules; Cells, Cultured; Cricetinae; Female; Flow Cytometry; Fluorescence Polarization; Humans; L-Selectin; Lipoproteins, LDL; Macrophage-1 Antigen; Male; Mesocricetus; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pentoxifylline; Platelet Activating Factor; Tetradecanoylphorbol Acetate | 1995 |
Prolonged activation of phospholipase D in Chinese hamster ovary cells expressing platelet-activating-factor receptor lacking cytoplasmic C-terminal tail.
Topics: 1-Butanol; Animals; CHO Cells; Cricetinae; Diglycerides; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation; Genes, fos; Genes, jun; Glycerophospholipids; Isoenzymes; Phosphatidic Acids; Phospholipase D; Platelet Activating Factor; Platelet Membrane Glycoproteins; Propranolol; Protein Kinase C; Protein Kinase C-alpha; Receptors, Cell Surface; Receptors, G-Protein-Coupled; RNA, Messenger; Transcription Factors; Type C Phospholipases | 1997 |
Pharmacological profile of (2R-trans)-4-[1-[3,5-bis(trifluoromethyl)benzoyl]-2-(phenylmethyl)-4-piperidinyl]-N-(2,6-dimethylphenyl)-1-acetamide (S)-Hydroxybutanedioate (R116301), an orally and centrally active neurokinin-1 receptor antagonist.
Topics: Administration, Oral; Allergens; Animals; Butanols; Capsaicin; Cats; Dogs; Edema; Ferrets; Gerbillinae; Guinea Pigs; Histamine; Kinetics; Malates; Mice; Motor Activity; Neurokinin-1 Receptor Antagonists; Piperidines; Platelet Activating Factor; Rabbits; Receptors, Neurokinin-1; Salivation; Substance P; Time Factors | 2002 |
Effects of ropivacaine on adhesion molecule CD11b expression and function in human neutrophils.
Topics: 1-Butanol; Amides; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; CD11 Antigens; Cell Adhesion; Egtazic Acid; Endothelial Cells; Humans; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phospholipase D; Platelet Activating Factor; Ropivacaine; Umbilical Veins | 2010 |